An imidazo[1,2-a]pyridine-pyridine derivative potently inhibits FLT3-ITD and FLT3-ITD secondary mutants, including gilteritinib-resistant FLT3-ITD/F691L-Reference-Cited by-同舟云学术

An imidazo[1,2-a]pyridine-pyridine derivative potently inhibits FLT3-ITD and FLT3-ITD secondary mutants, including gilteritinib-resistant FLT3-ITD/F691L

Published:2024-01 Issue: Volume:264 Page:115977
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Wang Xiuqi,DeFilippis Rosa Anna,Weldemichael Tsigereda,Gunaganti Naresh,Tran Phuc,Leung Yuet-Kin,Shah Neil P.,Li Hong-yu^ORCID

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference42 articles.

1. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia;Ley;N. Engl. J. Med.,2013

2. Comprehensive analysis of genetic alterations and their prognostic impacts in adult acute myeloid leukemia patients;Kihara;Leukemia,2014

3. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel;Dohner;Blood,2017

4. The conformational plasticity of protein kinases;Huse;Cell,2002

5. Conformational analysis of the DFG-out kinase motif and biochemical profiling of structurally validated type II inhibitors;Vijayan;J. Med. Chem.,2015

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Overcoming Secondary Mutations of Type II Kinase Inhibitors;Journal of Medicinal Chemistry;2024-06-05

2. New strategies to hit hematological cancers;European Journal of Medicinal Chemistry;2024-04

3. Discovery of FLT3-targeting PROTACs with potent antiproliferative activity against acute myeloid leukemia cells harboring FLT3 mutations;European Journal of Medicinal Chemistry;2024-03

4. Current progress in the synthesis of imidazoles and their derivatives via the use of green tools;Heterocyclic Communications;2024-01-01